You have 9 free searches left this month | for more free features.

txa127

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, Non-Hodgkin, Hodgkin Disease, Multiple Myeloma Trial in United States (TXA127, Placebo)

Terminated
  • Lymphoma, Non-Hodgkin
  • +2 more
  • TXA127
  • Placebo
  • Duarte, California
  • +9 more
Dec 7, 2020

COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • TXA127
  • +3 more
  • Birmingham, Alabama
  • +68 more
Jan 24, 2023

Thrombocytopenia, Neutropenia, Lymphopenia Trial in United States (TXA127, Placebo)

Completed
  • Thrombocytopenia
  • +3 more
  • TXA127
  • Placebo
  • Mobile, Alabama
  • +5 more
Oct 10, 2017

Miscellaneous Peripheral Blood Cell Abnormalities Trial in Tacoma (TXA127, Neupogen (filgrastim))

Completed
  • Miscellaneous Peripheral Blood Cell Abnormalities
  • TXA127
  • Neupogen (filgrastim)
  • Tacoma, Washington
    Charles River Clinical Servies Norhtwest
Aug 29, 2016

Hematologic Malignancies Trial in Charlottesville (TXA127)

Withdrawn
  • Hematologic Malignancies
  • TXA127
  • Charlottesville, Virginia
    University of Virginia Cancer Center
Aug 29, 2016

Myelodysplastic Syndrome (MDS) Trial in Houston (TXA127)

Terminated
  • Myelodysplastic Syndrome (MDS)
  • TXA127
  • Houston, Texas
    MD Anderson Leukemia Department
Aug 29, 2016

Hematologic Malignancies Trial in Atlanta, St Louis (TXA127)

Withdrawn
  • Hematologic Malignancies
  • TXA127
  • Atlanta, Georgia
  • +1 more
Aug 29, 2016

Cord Blood Transplant, Hematologic Malignancy, Inherited Metabolic Disease Trial in Durham (TXA127)

Withdrawn
  • Cord Blood Transplant
  • +2 more
  • TXA127
  • Durham, North Carolina
    Pediatric Bone and Cord Blood, Duke Univ. Med. Center
Aug 29, 2016